Efficacy and safety of oral alitretinoin as treatment for chronic hand eczema in France: a real-life open-label study

Background Chronic hand eczema is an inflammatory dermatosis that results in a significant psychological and socio-economic burden. Alitretinoin (AL) is indicated in adults with severe chronic hand eczema (sCHE) unresponsive to potent topical corticosteroids.